Ardent Health Q2 revenue $1.47B, adj. EBITDA $122M (+20%); issues FY24 guidance

Ardent Health, Inc.

2024-Q2 EPS reported $0.55 revenue$2,909,966,000

Q2 revenue $1.47B (+7.5% YoY); net income attributable $43M ($0.34/share).
Adjusted EBITDA $122M, up 20% YoY; adjusted admissions +3.4%.
Full-year 2024 guidance: revenue $5.75-5.90B, Adj. EBITDA $415-435M.
Cash from ops $120M (+$77M YoY); prepaid $100M term loan; net leverage 2.3x.
IPO net proceeds $209M (13.8M shares at $16); pro forma liquidity ~$832M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.